Additional panels, including the Myriad Genetics myRisk panel and the Color Hereditary cancer panel, expand beyond germline DDR mutations while incorporating other potential genes of interest, including PTEN, SMAD4, and STK11 [57,58]. Here, SMAD4 is linked to cancer.